capecitabine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, H; Inoshita, N; Ishida, A; Ogawa, W; Shichi, H; Yamada, S | 1 |
1 other study(ies) available for capecitabine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay.
Topics: Capecitabine; Dopamine Agonists; Humans; Pituitary Neoplasms; Prolactinoma; Temozolomide | 2022 |